TLCD4-RWDD3 readthrough (TLCD4-RWDD3)

TLCD4-RWDD3 readthrough is a protein-coding gene product produced by read-through transcription between the TMEM56 and RWDD3 genes, resulting in a transcript with a distinct C-terminus compared to the upstream gene product. The biological role, disease relevance, and clinical targeting status for this readthrough protein remain undefined. This entity is not a traditional receptor, enzyme, or transporter, but represents a read-through transcript that combines exons from two neighboring genes. It does not fit classic therapeutic target categories. This entry refers to a readthrough/putative chimeric transcript, not a validated drug target, and its precise function, disease connections, or therapeutic value are undetermined. The function of the readthrough protein, if it is expressed, remains speculative and poorly characterized. TLCD4-RWDD3 readthrough is a poorly characterized chimeric gene product, not considered a conventional therapeutic target, and lacks evidence for biological, clinical, or disease relevance as a standalone molecular entity.

Other names

TMEM56-RWDD3TMEM56-RWDD3 proteinTMEM56-RWDD3 readthroughTLCD4-RWDD3